$AMBQ

Esaka Fumihide sold $4.0M of AMBQ

Esaka Fumihide (Chief Executive Officer) sold 63,500 shares of Ambiq Micro, Inc. (AMBQ) at an average of $62.70 ($59.56–$63.86, $3.98M total) across 5 trades over 2026-09-11 to 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Esaka Fumihide
Published Sep 15, 2026, 10:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 11:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMBQ
Bearish
medium confidence
Mentioned
$AMBQ
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMBQBearishLow
01

Why it matters

The disclosed sale reduces the CEO's ownership, which could be interpreted as a lack of confidence, potentially prompting short sellers.

02

Market read

Insider sales are closely watched by traders; this $4M sale may trigger modest price movement in AMBQ.

03

What to watch

Potential upcoming product launches or contracts could offset the negative signal.

Relevance 5/10Novelty 4/10Timing: Filed Sep 15, 2026 (SEC Form 4)

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of corporate activity.

Company-level read

Ticker impact

$AMBQBearishMedium confidence
Context

CEO Esaka Fumihide sold 63,500 shares (~$4M) via a 10b5-1 plan, reducing his stake to 460,460 shares.

Expected impact

Potential modest downside pressure over the next few days.

Evidence & confidence

Insider sales by a CEO, even pre‑arranged, often lead to negative sentiment, especially for a micro‑cap like Ambiq.

Market effects

May weigh on other low‑cap semiconductor stocks as investors reassess insider confidence.

Limited to U.S. micro‑cap market; no broader regional effect.

Minimal global impact; relevance confined to Ambiq and its niche sector.

Counterpoint

The sale was pre‑arranged under a 10b5‑1 plan, so it may not reflect current sentiment.

Key entities

  • Ambiq Micro, Inc.

    U.S.-listed semiconductor firm (ticker AMBQ).

  • Esaka Fumihide

    Chief Executive Officer of Ambiq Micro.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.